What is Health2Sync?
Health2Sync offers data-driven digital therapeutics and personalized healthcare management services, primarily targeting patients with chronic conditions like diabetes. Their integrated platform, accessible via a user-friendly mobile app, allows individuals to monitor their health metrics and engage with healthcare professionals. By providing timely reminders and customized guidance, Health2Sync empowers users to actively manage their health and achieve better outcomes. The company prioritizes secure healthcare services, adhering to ISO standards for information security, which is crucial for building trust in the digital health space.
How much funding has Health2Sync raised?
Health2Sync has raised a total of $30.5M across 4 funding rounds:
Angel/Seed
$1.5M
Series A
$3M
Series B
$6M
Series C
$20M
Angel/Seed (2014): $1.5M, investors not publicly disclosed
Series A (2016): $3M led by Cherubic Ventures, iSeed Ventures, WI Harper Group, and SparkLabs Global Ventures
Series B (2017): $6M supported by Sompo Holdings, WI Harper, and Alibaba.com
Series C (2025): $20M featuring Wistron, Abies Capital, Cathay Innovation, Pegatron, and Taiwania Capital
Key Investors in Health2Sync
Cathay Innovation
Cathay Innovation is a global venture capital firm that supports entrepreneurs by connecting them to a worldwide ecosystem. The firm invests in multi-stage startups that are making a positive impact through technology, with a focus on sectors like finance and healthcare.
WI Harper
WI Harper Group is a venture capital firm specializing in early-stage investments, with a strong focus on healthcare and biotechnology. They leverage deep domain expertise to support bold entrepreneurs and have a track record of successful IPOs and M&A transactions.
SparkLabs Global Ventures
SparkLabs Global Ventures is a seed-stage fund dedicated to identifying and supporting exceptional entrepreneurs building category-defining companies globally. They provide practical guidance and mentorship to help founders scale their businesses internationally.
What's next for Health2Sync?
The recent major strategic investment signals a new phase of expansion for Health2Sync, likely focusing on scaling its operations, enhancing its technological capabilities, and broadening its market reach. This capital infusion will enable the company to further develop its digital therapeutics and personalized healthcare management services, potentially exploring new chronic disease areas or deepening its existing offerings for diabetes patients. Strategic partnerships and further technological integration are anticipated as Health2Sync aims to solidify its position as a leader in the digital health sector, leveraging its data-driven approach to improve patient outcomes and streamline healthcare delivery.
See full Health2Sync company page
